Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement.
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
accepted:
13
07
2019
pubmed:
23
7
2019
medline:
15
5
2021
entrez:
23
7
2019
Statut:
ppublish
Résumé
Low skin-related quality of life (QoL) is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. The way patients cope with a physical disease impacts significantly on their psychosocial adjustment to the disorder and on their emotional functioning. To explore how coping strategies, skin-related QoL, psychological distress and self-esteem interact in a sample of individuals with neurofibromatosis type 1 (NF1). Seventy-two adult patients with NF1 completed the following questionnaires: Coping Orientation to Problem Experiences (COPE), Skindex-29, Padua Skin-Related QoL questionnaire (PSRQ), State-Trait Anxiety Inventory-X2 form (STAI-X2), Depression Questionnaire (DQ) and Rosenberg Self-Esteem Scale (RSES). The k-modes algorithm was used to identify clusters of patients based on four variables: sex, NF1 severity, number and distribution of cutaneous neurofibromas. Individuals in different clusters were compared with regard to their scores; correlations between scores were analysed within each cluster. Two main clusters were identified: individuals in Cluster 1 had a larger number and more widespread distribution of neurofibromas compared with Cluster 2. Patients in Cluster 1 scored higher only on several PSRQ and Skindex-29 scales. Among patients in Cluster 1, the COPE 'avoidance strategies' scale was significantly correlated with the PSRQ 'physical distress and impairments' scale, the Skindex-29 'physical symptoms' and 'functioning' scales, the STAI-X2, the DQ and the RSES. Patients with major skin involvement have reduced skin-related QoL. Among them, current findings tentatively suggest that the higher the use of dysfunctional coping, the more impaired are QoL, psychological distress and self-esteem. What's already known about this topic? Neurofibromatosis type 1 (NF1) can affect the quality of life (QoL) in adolescent and adult patients. Low skin-related QoL is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. Questionnaires evaluating skin-related QoL, anxiety, depression, self-esteem and coping are available. What does this study add? Patients with a large number and a widespread distribution of cutaneous neurofibromas have reduced skin-related QoL compared with patients with minor skin involvement. The newly developed Padua Skin-Related QoL questionnaire allows the simultaneous evaluation of discomfort and comfort skin-related QoL dimensions in patients with NF1. Among patients with major skin involvement, the higher the use of dysfunctional coping, the more impaired are skin-related QoL, psychological distress and self-esteem. Our data suggest that patients with NF1 with major skin involvement who endorse dysfunctional beliefs about their own coping abilities might benefit from psychological counselling and coping skills treatments aiming to both improve perceived self-efficacy and learn more adaptive coping strategies.
Sections du résumé
BACKGROUND
Low skin-related quality of life (QoL) is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. The way patients cope with a physical disease impacts significantly on their psychosocial adjustment to the disorder and on their emotional functioning.
OBJECTIVES
To explore how coping strategies, skin-related QoL, psychological distress and self-esteem interact in a sample of individuals with neurofibromatosis type 1 (NF1).
METHODS
Seventy-two adult patients with NF1 completed the following questionnaires: Coping Orientation to Problem Experiences (COPE), Skindex-29, Padua Skin-Related QoL questionnaire (PSRQ), State-Trait Anxiety Inventory-X2 form (STAI-X2), Depression Questionnaire (DQ) and Rosenberg Self-Esteem Scale (RSES). The k-modes algorithm was used to identify clusters of patients based on four variables: sex, NF1 severity, number and distribution of cutaneous neurofibromas. Individuals in different clusters were compared with regard to their scores; correlations between scores were analysed within each cluster.
RESULTS
Two main clusters were identified: individuals in Cluster 1 had a larger number and more widespread distribution of neurofibromas compared with Cluster 2. Patients in Cluster 1 scored higher only on several PSRQ and Skindex-29 scales. Among patients in Cluster 1, the COPE 'avoidance strategies' scale was significantly correlated with the PSRQ 'physical distress and impairments' scale, the Skindex-29 'physical symptoms' and 'functioning' scales, the STAI-X2, the DQ and the RSES.
CONCLUSIONS
Patients with major skin involvement have reduced skin-related QoL. Among them, current findings tentatively suggest that the higher the use of dysfunctional coping, the more impaired are QoL, psychological distress and self-esteem. What's already known about this topic? Neurofibromatosis type 1 (NF1) can affect the quality of life (QoL) in adolescent and adult patients. Low skin-related QoL is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. Questionnaires evaluating skin-related QoL, anxiety, depression, self-esteem and coping are available. What does this study add? Patients with a large number and a widespread distribution of cutaneous neurofibromas have reduced skin-related QoL compared with patients with minor skin involvement. The newly developed Padua Skin-Related QoL questionnaire allows the simultaneous evaluation of discomfort and comfort skin-related QoL dimensions in patients with NF1. Among patients with major skin involvement, the higher the use of dysfunctional coping, the more impaired are skin-related QoL, psychological distress and self-esteem. Our data suggest that patients with NF1 with major skin involvement who endorse dysfunctional beliefs about their own coping abilities might benefit from psychological counselling and coping skills treatments aiming to both improve perceived self-efficacy and learn more adaptive coping strategies.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1449-1457Informations de copyright
© 2019 British Association of Dermatologists.
Références
Clementi M, Barbujani G, Turolla L et al. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 1990; 84:116-18.
Ferner RE, Huson SM, Thomas N et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007; 44:81-8.
Hersh JH. American Academy of Pediatrics Committee on Genetics. Health supervision for children with neurofibromatosis. Pediatrics 2008; 121:633-42.
Stevenson DA, Little D, Armstrong L et al. Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium. J Pediatr Orthoped 2013; 33:269-75.
Trevisson E, Cassina M, Opocher E et al. Natural history of optic pathway gliomas in a cohort of unselected patients affected by neurofibromatosis 1. J Neuro-Oncol 2017; 134:279-87.
Reilly KM, Kim A, Blakely J et al. Neurofibromatosis type 1-associated MPNST state of the science: outlining a research agenda for the future. J Natl Cancer Inst 2017; 109:djx124.
Parrozzani R, Pilotto E, Clementi M et al. Retinal vascular abnormalities in a large cohort of patients affected by neurofibromatosis type 1. A study using optical coherence tomography angiography. Retina 2018; 38:585-93.
Acosta MT, Bearden CE, Castellanos FX et al. The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research. Am J Med Genet A 2012; 158A:2225-32.
Hyman SL, Arthur Shores E, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2006; 48:973-7.
Granstrom S, Langenbruch A, Augustin M et al. Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image. Dermatology 2012; 224:160-7.
Vranceanu AM, Merker VL, Park E et al. Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol 2013; 114:257-62.
Wang DL, Smith KB, Esparza S et al. Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 2012; 14:977-82.
Wolkenstein P, Zeller J, Revuz J et al. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 2001; 137:1421-5.
Gupta MA, Gupta AK. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. Clin Dermatol 2013; 31:72-9.
Dalgard FJ, Gieler U, Tomas-Aragones L et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135:984-91.
Cohen JS, Levy HP, Sloan J et al. Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet 2015; 88:425-30.
Ferner RE, Thomas M, Mercer G et al. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Health Qual Life Outcomes 2017; 15:34.
Cohen S, Rodriguez MS. Pathways linking affective disturbances and physical disorders. Health Psychol 1995; 14:374-80.
Folkman S. Stress, coping, and hope. Psycho-Oncology 2010; 19:901-8.
Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer, 1984.
National Institutes of Health. Consensus development conference statement. Neurofibromatosis. Arch Neurol-Chicago 1988; 45:575-8.
Bottesi G, Gion A, Baratto G et al. The assessment of skin-related QoL in individuals dissatisfied with their skin: factor structure and responsiveness of the Padua Skin-Related QoL Questionnaire. J Cogn Behav Psychother 2018; 18:81-93.
Chren MM, Lasek RJ, Flocke SA et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133:1433-40.
Abeni D, Picardi A, Pasquini P et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204:43-9.
Spielberger CD, Gorsuch RL, Lushene RE. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
Lazzari R, Pancheri P. STAI Questionario di autovalutazione dell'ansia di stato e di tratto. Firenze, Italy: Organizzazioni Speciali, 1980.
Bertolotti G, Michielin P, Vidotto G et al. Depression Questionnaire (DQ). In: Practitioner's Guide to Empirically-Based Measures of Depression. Norwell, MA: Kluwer Academic/Plenum Publishers, 2000.
Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989; 56:267-83.
Sica C, Magni C, Ghisi M et al. Coping Orientation to Problems Experienced-Nuova Versione Italiana (COPE-NVI): uno strumento per la misura degli stili di coping. Psicoterapia Cognitiva e Comportamentale 2008; 14:27-53.
Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press, 1965.
Prezza M, Trombaccia FR, Armento L. La scala dell'autostima di Rosenberg: traduzione e validazione Italiana. Bollettino di Psicologia Applicata 1997; 223:35-44.
Riccardi VM, Kleiner B. Neurofibromatosis: a neoplastic birth defect with two age peaks of severe problems. Birth Defects Orig Artic Ser 1977; 13:131-8.
de Chiusole D, Spoto A, Stefanutti L. Extracting partially ordered clusters from ordinal polytomous data. Behav Res Methods 2019; https://doi.org/10.3758/s13428-019-01248-8.
de Chiusole D, Stefanutti L, Spoto A. A class of k-modes algorithms for extracting knowledge structures from data. Behav Res Methods 2017; 49:1212-26.
Huang ZX. Extensions to the k-means algorithm for clustering large data sets with categorical values. Data Min Knowl Disc 1998; 2:283-304.
Hartigan JA, Wong MA. Algorithm AS 136: a k-means clustering algorithm. J R Stat Soc Series C (Applied Statistics) 1979; 28:100-8.
Gelman A, Carlin JB, Stern HS et al. Bayesian Data Analysis. London: Chapman and Hall/CRC, 2013.
Lee MD, Wagenmakers E-J. Bayesian Cognitive Modeling: A practical course. Cambridge: Cambridge University Press, 2013.
Held L, Ott M. How the maximal evidence of P-values against point null hypotheses depends on sample size. Am Stat 2016; 70:335-41.
Baumstarck K, Leroy T, Hamidou Z et al. Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life. J Neurooncol 2016; 129:155-64.
Hamidou Z, Auquier P, Leroy T et al. Dyadic effects of coping strategies, time perspectives, and personality on the quality of life of cancer patients and their caregivers. Psychooncology 2018; 27:590-9.
Burns RJ, Deschenes SS, Schmitz N. Associations between coping strategies and mental health in individuals with type 2 diabetes: prospective analyses. Health Psychol 2016; 35:78-86.
Macrodimitris SD, Endler NS. Coping, control, and adjustment in type 2 diabetes. Health Psychol 2001; 20:208-16.
Rinaldi S, Ghisi M, Iaccarino L et al. Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus. Arthrit Rheum-Arthr 2006; 55:427-33.